Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
152.80    -0.20 (-0.13%)
Bid:
153.20
Ask:
153.60
Spread: 0.40 (0.261%)
Market Cap: £874.50m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

Directorate Change

24 Dec 2024 07:00

RNS Number : 1972R
Elementis PLC
24 December 2024
 

24 December 2024

 

Elementis plc

Directorate Change

Elementis plc (the "Company"), global specialty chemicals company, today announces the appointment of Christopher Mills as a Non-Executive Director with effect from 1 January 2025.

Mr Mills founded Harwood Capital Management in 2011, a successor to its former parent company JO Hambro Capital Management, which he co-founded in 1993 and of which he was formerly the Chief Investment Officer. He is currently the Chief Executive Officer and Investment Manager of North Atlantic Smaller Companies Investment Trust plc, a UK listed investment trust, and a Non-Executive Director of several companies including Assetco plc, MJ Gleeson plc, PRS REIT plc and Oryx International Growth Fund Limited.

Mr Mills has indicated that he will donate his director fees received from the Company to the Harwood Charitable Trust, which provides educational support, mainly for doctors in Africa.

As at the date of this announcement, funds managed by Harwood Capital Management and its affiliates own 22.5 million shares in the Company.

The Board shares the frustration of many shareholders with the Company's valuation, which it believes has not reflected the quality of the business and its assets for some time. Mr Mills will support the Board on completing existing initiatives, including the strategic review of Talc, and potentially new initiatives to narrow the gap between the share price and the Company's intrinsic value.

John O'Higgins, Chair of the Board of the Company, said:

"We welcome Christopher to the Board, and look forward to benefiting from his track record of helping contribute to long term shareholder value creation."

The following information is disclosed in accordance with UKLR 6.4.8R(1) in relation to Mr Mills:

Current directorships*

Previous directorships in the past five years*

Assetco plc

Augean plc

Bigblu Broadband plc

Curtis Banks Group Limited

Catalyst Media Group plc

Gabelli Value Plus+ Trust plc

EKF Diagnostics Holdings plc

Goals Soccer Centres plc

Frenkel Topping Group plc

Sunlink Health Systems Inc

MJ Gleeson Plc

Ten Entertainment Group plc

North Atlantic Smaller Companies Investment Trust plc

Trellus Health plc

Oryx International Growth Fund Limited

Sureserve Group plc

Renalytix plc

The PRS REIT plc

Hipgnosis Songs Fund Limited

 

*other publicly quoted companies only

The Company confirms that there are no other matters requiring disclosure pursuant to UKLR 6.4.8R (1) to (6) in respect of Mr Mills's appointment.

Enquiries

 

Elementis:

Anna Lawrence, Group General Counsel & Company Secretary: 020 8148 5966

Eva Hatfield, Head of Investor Relations: 07553 340380

 

Teneo:

 

Olivia Peters: 020 7353 4200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUOAARSBUUUUA
Date   Source Headline
8th Jun 20265:14 pmRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSCommencement of share buyback programme
2nd Jun 20267:00 amRNSSale of Pharma business & intended buyback launch
1st Jun 20269:58 amRNSTotal Voting Rights
5th May 20265:26 pmRNSHolding(s) in Company
1st May 20269:59 amRNSTotal Voting Rights
29th Apr 20263:47 pmRNSResult of AGM
29th Apr 20267:00 amRNSFirst quarter trading update
8th Apr 20264:14 pmRNSDirector/PDMR Shareholding
7th Apr 20263:06 pmRNSDirector/PDMR Shareholding
1st Apr 202610:18 amRNSTotal Voting Rights
30th Mar 20265:06 pmRNSCorrection - Admission to Trading
30th Mar 20261:58 pmRNSAdmission to Trading
26th Mar 202612:09 pmRNSNotice of AGM and Annual Report & Accounts
19th Mar 20267:00 amRNSDirectorate change
11th Mar 20263:18 pmRNSDirector/PDMR Shareholding
11th Mar 20263:18 pmRNSDirector/PDMR Shareholding
10th Mar 20263:40 pmRNSDirector/PDMR Shareholding
10th Mar 20263:40 pmRNSDirector/PDMR Shareholding
10th Mar 20263:39 pmRNSDirector/PDMR Shareholding
9th Mar 20265:14 pmRNSHolding(s) in Company
5th Mar 20265:11 pmRNSBlocklisting Interim Review
5th Mar 20264:57 pmRNSPreliminary Results - Correction
5th Mar 20267:00 amRNSPreliminary Results
2nd Mar 202610:00 amRNSTotal Voting Rights
25th Feb 20264:22 pmRNSDirectorate change
2nd Feb 202610:05 amRNSTotal Voting Rights
21st Jan 20267:00 amRNSTrading Update
2nd Jan 202611:10 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSConfirmation of Board changes
2nd Jan 20267:00 amRNSConfirmation of Board changes
24th Dec 202510:25 amRNSDirector/PDMR Shareholding
24th Dec 202510:25 amRNSDirector/PDMR Shareholding
15th Dec 20257:00 amRNSCompletion of Buyback programme
15th Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20255:35 pmRNSTransaction in Own Shares
10th Dec 20256:12 pmRNSTransaction in Own Shares
9th Dec 20255:55 pmRNSTransaction in Own Shares
8th Dec 20255:52 pmRNSTransaction in Own Shares
8th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20256:06 pmRNSTransaction in Own Shares
3rd Dec 20255:28 pmRNSTransaction in Own Shares
3rd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20255:49 pmRNSTransaction in Own Shares
28th Nov 20255:49 pmRNSTransaction in Own Shares
27th Nov 20255:40 pmRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20257:00 amRNSElementis acquires personal care specialist
25th Nov 20255:44 pmRNSTransaction in Own Shares
24th Nov 20256:01 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.